Generating CD63-GFP Exosomal Vesicles
Corresponding Organization : Osaka Prefecture University
Other organizations : Mukogawa Women's University, Kyoto Bunkyo University, Kyoto University
Variable analysis
- Transfection of CD63-GFP plasmid (pCT-CD63-GFP, pCMV, Cyto-Tracer, System Biosciences, Mountain View, CA) (800 ng) complexed with Lipofectamine LTX reagent (2 μl) and PLUS reagent (1 μl) (Invitrogen, Life Technologies Corporation, Eugene, OR, USA)
- Secretion of CD63-GFP-containing EVs (CD63-GFP EVs)
- HeLa cells (1 × 10^5 cells) plated on a 24-well microplate (Iwaki, Tokyo, Japan) and incubated for 1 day
- α-MEM containing 10% FBS (200 μl)
- Treatment with puromycin (3 μg/ml) (LKT Laboratories, St. Paul, MN) for the antibiotic selection of HeLa cells stably expressing CD63-GFP (CD63-GFP-HeLa)
- Not explicitly mentioned
- Not explicitly mentioned
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!